Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Clinical trial NCT03281954 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03281954
- Sponsor
- NSABP Foundation Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2024-12-31
- Enrollment
- 1550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.